Xavier Moisset

71PUBLICATIONS
216CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyMedical microbiology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (71)

|Sep 26, 2026
Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Aug 04, 2026
Borrelia miyamotoi meningoradiculitis complicating ocrelizumab treatment for multiple sclerosis: A report of three cases.

|Jun 02, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

|May 22, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

|May 06, 2026
Kappa free light chain index or oligoclonal bands testing in clinical practice for multiple sclerosis diagnosis: An algorithm comparative study.

Pageof 12

Frequent Collaborators

25 joint publications

Jonathan Ciron

19 joint publications

Sandra Vukusic

19 joint publications

Eric Thouvenot

18 joint publications

Romain Marignier